Home
>
National Drug Code (NDC)
>
Ramipril
Ramipril - 21695-821-30 - (ramipril)
Drug Information of Ramipril
| Product NDC: | 21695-821 |
| Proprietary Name: | Ramipril |
| Non Proprietary Name: | ramipril |
| Active Ingredient(s): | 2.5 mg/1 & nbsp; ramipril |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Ramipril
| Product NDC: | 21695-821 |
| Labeler Name: | Rebel Distributors Corp |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA076549 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20071226 |
Package Information of Ramipril
| Package NDC: | 21695-821-30 |
| Package Description: | 30 CAPSULE in 1 BOTTLE (21695-821-30) |
NDC Information of Ramipril
| NDC Code | 21695-821-30 |
| Proprietary Name | Ramipril |
| Package Description | 30 CAPSULE in 1 BOTTLE (21695-821-30) |
| Product NDC | 21695-821 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | ramipril |
| Dosage Form Name | CAPSULE |
| Route Name | ORAL |
| Start Marketing Date | 20071226 |
| Marketing Category Name | ANDA |
| Labeler Name | Rebel Distributors Corp |
| Substance Name | RAMIPRIL |
| Strength Number | 2.5 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA] |
